Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vincenzo Mettivier

Major Molecular Response Induced by Nilotinib as First Line Treatment in a LMC Patient With Intermediate Sokal Risk

Clinical Management Issues

English

Related publications

Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib

Clinical Management Issues

English

Nilotinib in Der First-Line Zugelassen

English

Nilotinib Übertrifft Imatinib in Der First-Line Weiterhin

English

Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Single Patient Experience

American Journal of Hematology

English

Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib

Hematology Reports

English

Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience

American Journal of Hematology

English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

Value in Health

Occupational Health

English

P3.15-27 Initial Response to First Line Treatment Is the Best Predictor of the Patient Survival in Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Long-Term Response to First-Line Trabectedin in an Elderly Female Patient With a Metastatic Leiomyosarcoma Unfit for Anthracycline

Anti-Cancer Drugs

Cancer Research

English